Anti-TRAF3IP2 Antibody

Raised in rabbit and supplied unconjugated as a 100 µl liquid in a vial, this polyclonal reagent from Antibodies.com recognizes TRAF3IP2, an intracellular signaling adapter also known as ACT1 or CIKS that bridges TNF receptor-associated factor proteins to downstream immune pathways. Investigators studying IL-17 receptor signaling, Th17-driven inflammation, and autoimmune disease biology employ the antibody in western blot and immunohistochemistry workflows on human samples. Its target functions as a key link between TRAF family members and NF-κB activation, with documented relevance in psoriatic skin inflammation and lymphoid tissue studies. Recommended for research use only, the antibody supports detection of endogenous TRAF3IP2 expression in cell lysates and formalin-fixed paraffin-embedded tissue sections.